Analysts: BioScrip Inc (BIOS.O)
BIOS.O on Nasdaq
13.60USD
23 May 2013
13.60USD
23 May 2013
Price Change (% chg)
$-0.06 (-0.44%)
$-0.06 (-0.44%)
Prev Close
$13.66
$13.66
Open
$13.33
$13.33
Day's High
$13.63
$13.63
Day's Low
$13.25
$13.25
Volume
252,106
252,106
Avg. Vol
607,636
607,636
52-wk High
$14.73
$14.73
52-wk Low
$6.14
$6.14
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.04 | December | 23 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 2 | 1 | 1 |
| (2) OUTPERFORM | 3 | 3 | 3 | 3 |
| (3) HOLD | 1 | 1 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.71 | 1.83 | 1.75 | 1.75 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 5 | 206.46 | 211.60 | 203.50 | 163.97 |
| Quarter Ending Sep-13 | 5 | 215.82 | 220.00 | 207.65 | 165.86 |
| Year Ending Dec-13 | 6 | 851.59 | 860.57 | 842.70 | 661.46 |
| Year Ending Dec-14 | 6 | 963.64 | 1,032.00 | 918.00 | 700.00 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 6 | 0.04 | 0.06 | 0.02 | 0.10 |
| Quarter Ending Sep-13 | 6 | 0.08 | 0.11 | 0.06 | 0.12 |
| Year Ending Dec-13 | 3 | 0.31 | 0.35 | 0.28 | 0.45 |
| Year Ending Dec-14 | 6 | 0.47 | 0.56 | 0.38 | 0.54 |
| LT Growth Rate (%) | 2 | 16.00 | 17.00 | 15.00 | 22.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 189.36 | 199.07 | 9.71 | 5.13 |
| Quarter Ending Dec-12 | 173.87 | 180.74 | 6.87 | 3.95 |
| Quarter Ending Sep-12 | 160.46 | 170.37 | 9.90 | 6.17 |
| Quarter Ending Jun-12 | 153.76 | 155.90 | 2.14 | 1.39 |
| Quarter Ending Dec-11 | 458.88 | 483.30 | 24.42 | 5.32 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.02 | 0.04 | 0.02 | 100.00 |
| Quarter Ending Dec-12 | 0.01 | -0.03 | 0.04 | 500.00 |
| Quarter Ending Sep-12 | -0.01 | -0.01 | 0.00 | -0.00 |
| Quarter Ending Jun-12 | -0.01 | -0.07 | 0.06 | -600.00 |
| Quarter Ending Mar-12 | -0.00 | -0.04 | 0.04 | -700.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 206.46 | 206.72 | 203.57 | 204.07 | 163.97 |
| Quarter Ending Sep-13 | 215.82 | 217.86 | 216.56 | 215.82 | 165.86 |
| Year Ending Dec-13 | 851.59 | 853.37 | 837.70 | 838.72 | 661.46 |
| Year Ending Dec-14 | 963.64 | 964.51 | 939.41 | 941.29 | 700.00 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 0.04 | 0.04 | 0.05 | 0.05 | 0.10 |
| Quarter Ending Sep-13 | 0.08 | 0.08 | 0.08 | 0.08 | 0.12 |
| Quarter Ending Dec-13 | 0.31 | 0.31 | 0.25 | 0.26 | 0.45 |
| Quarter Ending Dec-14 | 0.47 | 0.46 | 0.46 | 0.49 | 0.54 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-13 | 0 | 0 | 4 | 0 |
| Quarter Ending Sep-13 | 0 | 0 | 3 | 1 |
| Year Ending Dec-13 | 0 | 0 | 5 | 0 |
| Year Ending Dec-14 | 0 | 0 | 5 | 0 |
| Earnings | ||||
| Quarter Ending Jun-13 | 0 | 0 | 1 | 3 |
| Quarter Ending Sep-13 | 0 | 0 | 2 | 1 |
| Year Ending Dec-13 | 0 | 0 | 3 | 0 |
| Year Ending Dec-14 | 0 | 0 | 2 | 2 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates